On October 29, 2021, State Health Director Dr. Betsey Tilson issued new Statewide Standing Orders for Monoclonal Antibody Therapy for COVID-19. 

NC State Health Director’s Statewide Standing Order for Intravenous Administration of Sotrovimab Monoclonal Antibodies, October 29, 2021 

NC State Health Director’s Statewide Standing Order for Intravenous Administration of Bamlanivimab/Etesevimab Monoclonal Antibodies, October 29, 2021 

More information concerning the US DHHS PREP Act declaration authorizing pharmacists to order and administer select COVID-19 therapeutics is found here. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.